A leading clinical-stage biotechnology company developing gene therapies for retinal, metabolic, and neurodegenerative diseases implemented IDBS PIMS to modernize batch data management and strengthen collaboration with contract manufacturing organizations (CMOs). The company relied on multiple external partners to manufacture AAV viral vectors and needed to move away from spreadsheet-based processes toward a centralized data repository. Its goals included accelerating data delivery from manufacturing partners, improving accessibility and consistency of process information, and preparing for the rigorous data management requirements associated with process validation and commercialization. By adopting IDBS PIMS, the organization democratized access to batch and manufacturing data, enhanced

Join for free to read